Prelude Capital Management’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $302K | Buy |
24,684
+3,984
| +19% | +$48.8K | 0.03% | 607 |
|
|
2025
Q1 | $297K | Buy |
20,700
+8,241
| +66% | +$118K | 0.02% | 630 |
|
|
2024
Q4 | $198K | Buy |
+12,459
| New | +$198K | 0.01% | 872 |
|
|
2024
Q1 | – | Sell |
-14,593
| Closed | -$327K | – | 1204 |
|
|
2023
Q4 | $327K | Buy |
14,593
+4,431
| +44% | +$99.4K | 0.02% | 599 |
|
|
2023
Q3 | $205K | Buy |
+10,162
| New | +$205K | 0.01% | 748 |
|
|
2020
Q4 | – | Sell |
-2,320
| Closed | -$77K | – | 820 |
|
|
2020
Q3 | $77K | Sell |
2,320
-900
| -28% | -$29.9K | ﹤0.01% | 759 |
|
|
2020
Q2 | $95K | Buy |
3,220
+20
| +0.6% | +$590 | 0.01% | 675 |
|
|
2020
Q1 | $86K | Buy |
+3,200
| New | +$86K | 0.01% | 388 |
|
|
2019
Q1 | – | Sell |
-7,042
| Closed | -$315K | – | 1345 |
|
|
2018
Q4 | $315K | Buy |
7,042
+1,793
| +34% | +$80.2K | 0.02% | 393 |
|
|
2018
Q3 | $360K | Buy |
+5,249
| New | +$360K | 0.02% | 411 |
|
|
2016
Q4 | – | Sell |
-14,699
| Closed | -$509K | – | 1489 |
|
|
2016
Q3 | $509K | Buy |
14,699
+5,547
| +61% | +$192K | 0.05% | 274 |
|
|
2016
Q2 | $298K | Buy |
9,152
+2,352
| +35% | +$76.6K | 0.04% | 360 |
|
|
2016
Q1 | $195K | Buy |
6,800
+4,100
| +152% | +$118K | 0.03% | 500 |
|
|
2015
Q4 | $90K | Buy |
+2,700
| New | +$90K | 0.01% | 792 |
|
|
2015
Q3 | – | Sell |
-1,000
| Closed | -$41K | – | 1378 |
|
|
2015
Q2 | $41K | Buy |
+1,000
| New | +$41K | 0.01% | 1132 |
|